This isn’t Cytonics’s most recent raise. Reg CF · Common Stock · Feb 2026 (Open) is more current.View latest round
via DealMaker · last checked Aug 17, 2026
Raised
$1.7M / $2M max
89% of ceiling
Investors
—
—
Valuation
—
—
Financials disclosed in this offering
FY2020–FY2021 · hover for source$591K
−$996K
FY2020
$308K
$2.5M
FY2021
RevenueNet income
Metric
FY2020 audited
FY2021 audited
Income statement
Revenue
$591,056
$307,500
Cost of goods sold
$0
$0
Gross margin
100%
100%
Net income
-$995,850
$2,544,189
Taxes paid
$0
$0
Balance sheet
Cash
$537,354
$967,757
Accounts receivable
$80,000
$123,333
Total assets
$1,466,746
$1,756,758
Short-term debt
$157,633
$554,929
Long-term debt
$1,961,904
$0
Total liabilities
$2,508,163
$554,929
Other
Headcount
1
1
The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Deal terms
Price / share$2.30
Shares offered10,870
Offering details
Target$25,000
Max$1,951,220
Min investment—
OpenedNov 23, 2022
DeadlineApr 1, 2023
ClosedApr 1, 2023
Days active129
Links & provenance
Source: SEC EDGAR
0001104659-22-121375
Last synced Aug 17, 2026
0001104659-22-121375
Last synced Aug 17, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.